State of Wisconsin Investment Board
SGTX

State of Wisconsin Investment Board’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History

State of Wisconsin Investment Board’s Portfolio SGTX Stock Details SGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-39,202
Closed -$882K – 2645
2023
Q2 		$882K Hold
39,202
– – ﹤0.01% 1507
2023
Q1 		$474K Hold
39,202
– – ﹤0.01% 1893
2022
Q4 		$178K Hold
39,202
– – ﹤0.01% 2269
2022
Q3 		$257K Hold
39,202
– – ﹤0.01% 2297
2022
Q2 		$423K Hold
39,202
– – ﹤0.01% 2160
2022
Q1 		$749K Hold
39,202
– – ﹤0.01% 1703
2021
Q4 		$1.41M Hold
39,202
– – ﹤0.01% 1355
2021
Q3 		$2.88M Hold
39,202
– – 0.01% 1203
2021
Q2 		$5.47M Hold
39,202
– – 0.01% 1015
2021
Q1 		$11.4M Hold
39,202
– – 0.02% 685
2020
Q4 		$24.5M Buy
+39,202
New +$17.8M 0.06% 354

Other funds holding SGTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

State of Wisconsin Investment Board's SGTX Position: Q3 2023 in Review

State of Wisconsin Investment Board sold out of Sigilon Therapeutics, Inc. Common Stock (SGTX) in Q3 2023, closing a stake of 39,202 shares — an estimated $882K sold.

State of Wisconsin Investment Board first reported a position in SGTX in Q4 2020 and held it in 11 quarters. The position peaked at $24.5M in Q4 2020. 1 fund tracked by Wall St. Rank holds SGTX as of Q3 2023.

  • State of Wisconsin Investment Board reported no remaining Sigilon Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 39,202 Sigilon Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $882K.
  • State of Wisconsin Investment Board first reported a position in Sigilon Therapeutics, Inc. Common Stock in Q4 2020 and held it in 11 quarters.
  • State of Wisconsin Investment Board's Sigilon Therapeutics, Inc. Common Stock position peaked at $24.5M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held Sigilon Therapeutics, Inc. Common Stock as of Q3 2023.

Based on State of Wisconsin Investment Board's 13F filing for Q3 2023, filed 14 Nov 2023.